Usability and feasibility of consumer-facing technology to reduce unsafe medication use by older adults

dc.contributor.authorHolden, Richard J.
dc.contributor.authorCampbell, Noll L.
dc.contributor.authorAbebe, Ephrem
dc.contributor.authorClark, Daniel O.
dc.contributor.authorFerguson, Denisha
dc.contributor.authorBodke, Kunal
dc.contributor.authorBoustani, Malaz A.
dc.contributor.authorCallahan, Christopher M.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2019-03-15T18:56:37Z
dc.date.available2019-03-15T18:56:37Z
dc.date.issued2019
dc.description.abstractBackground Mobile health technology can improve medication safety for older adults, for instance, by educating patients about the risks associated with anticholinergic medication use. Objective This study's objective was to test the usability and feasibility of Brain Buddy, a consumer-facing mobile health technology designed to inform and empower older adults to consider the risks and benefits of anticholinergics. Methods Twenty-three primary care patients aged ≥60 years and using anticholinergic medications participated in summative, task-based usability testing of Brain Buddy. Self-report usability was assessed by the System Usability Scale and performance-based usability data were collected for each task through observation. A subset of 17 participants contributed data on feasibility, assessed by self-reported attitudes (feeling informed) and behaviors (speaking to a physician), with confirmation following a physician visit. Results Overall usability was acceptable or better, with 100% of participants completing each Brain Buddy task and a mean System Usability Scale score of 78.8, corresponding to “Good” to “Excellent” usability. Observed usability issues included higher rates of errors, hesitations, and need for assistance on three tasks, particularly those requiring data entry. Among participants contributing to feasibility data, 100% felt better informed after using Brain Buddy and 94% planned to speak to their physician about their anticholinergic related risk. On follow-up, 82% reported having spoken to their physician, a rate independently confirmed by physicians. Conclusion Consumer-facing technology can be a low-cost, scalable intervention to improve older adults’ medication safety, by informing and empowering patients. User-centered design and evaluation with demographically heterogeneous clinical samples uncovers correctable usability issues and confirms the value of interventions targeting consumers as agents in shared decision making and behavior change.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationHolden, R. J., Campbell, N. L., Abebe, E., Clark, D. O., Ferguson, D., Bodke, K., … Callahan, C. M. (2019). Usability and feasibility of consumer-facing technology to reduce unsafe medication use by older adults. Research in Social and Administrative Pharmacy. https://doi.org/10.1016/j.sapharm.2019.02.011en_US
dc.identifier.urihttps://hdl.handle.net/1805/18626
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.sapharm.2019.02.011en_US
dc.relation.journalResearch in Social and Administrative Pharmacyen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectmedicationsen_US
dc.subjectinformation technologyen_US
dc.subjectshared decision makingen_US
dc.titleUsability and feasibility of consumer-facing technology to reduce unsafe medication use by older adultsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Holden_2019_usability.pdf
Size:
1.02 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: